Co-Diagnostics announces 1-for-30 reverse stock split

1 hour ago 1

Skip to navigation Skip to main contented Skip to close file

TipRanks

Wed, December 31, 2025 astatine 8:10 AM CST 1 min read

Co-Diagnostics (CODX) announced that it has filed a Certificate of Amendment to its Certificate of Incorporation to effect a reverse banal divided of its communal banal astatine a ratio of 1-for-30 shares. The reverse banal divided volition go effectual astatine 12:01 a.m. ET connected Friday, January 2, 2026. Co-Dx’s communal banal volition proceed to commercialized connected The Nasdaq Capital Market nether the awesome “CODX” and volition statesman trading connected a split-adjusted ground erstwhile the marketplace opens connected Friday, January 2, 2026. The reverse banal divided is intended to alteration the Company to regain compliance with the $1.00 minimum bid terms request for continued listing connected The Nasdaq Capital Market. The caller CUSIP fig for Co-Dx’s communal banal pursuing the reverse banal divided volition beryllium 189763 204.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected CODX:

Disclaimer & DisclosureReport an Issue

Co-Diagnostics receives assistance of Australian Patent covering Co-Dx PCR tech
Co-Diagnostics: Differentiated Multiplex PCR Platform and H3N2 Alignment Drive Favorable Risk–Reward and Buy Rating
Co-Diagnostics reports results from silico investigation of Co-Primers successful Logix test
Co-Diagnostics Approves Reverse Stock Split Proposal
Coterra, Ovintiv, Nektar, Co-Diagnostics, Fluence: Trending by Analysts

Read Entire Article